Tri-lo- Estarylla Kit
Product Images NDC 70700-120

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tri-lo- Estarylla (NDC 70700-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 2

A forest plot chart illustrating effect estimates (odds ratios or relative risks) with confidence intervals for various women's health studies conducted between 2002 and 2017. The horizontal axis ranges from -1.5 to 2, focusing on values near 1, with individual studies listed on the left and corresponding numerical effect estimates with confidence intervals on the right.*

FDA Label Image

Figure (Ortho Tri Cyclen 09)

An illustration diagram showing the relative effectiveness of various birth control methods based on pregnancies per 100 women per year. It categorizes methods from fewer pregnancies to more pregnancies, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring, condoms, diaphragm, no sex during fertile days, spermicide, withdrawal, and no birth control.*

FDA Label Image

Structure (Structure)

Chemical structures of the active ingredients in Tri-Lo- Estarylla: Norgestimate and Ethinyl Estradiol. The image shows the molecular diagrams labeled with their respective names, depicting atoms, bonds, and functional groups typical for these steroid hormones.*

FDA Label Image

Tri-lo-carton (Tri Lo Carton)

Tri-Lo-Estarylla kit packaging label from Xiromed, LLC featuring norgestimate and ethinyl estradiol tablets, USP. The label lists strengths 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg. The package contains 3 units of 3x28 tablet blister cards. The design includes blue and green colors with dosage and safety information for prescription use only.*

FDA Label Image

Tri-lo (Tri Lo Estarylla)

Tri-Lo- Estarylla kit containing norgestimate and ethinyl estradiol tablets USP at strengths of 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg. The label shows a 28-day blister pack with circle indicators for each day of the week labeled from Sunday to Saturday for four weeks. The first three weeks have unshaded circles, and the fourth week has shaded circles, indicating active and inactive tablets, respectively. The labeler is Xiromed, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.